All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 3, 2021

Briefs

  • Briefs
    • Deals and M&A
    • Appointments and advancements
    • Earnings
    • In the clinic
    • Other news to note
    • Regulatory actions
    • Stock
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Post market
    • Preclinical
    • Products Regulatory
    • Products Clinical
Home » Topics » Briefs
  • March 2, 2021

    Regulatory actions for Feb. 23-March 1, 2021

    Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Astrazeneca, Biontech, Cansino, Carsgen, Gannex, GC, Harbour Biomed, Iaso, Idorsia, Innovent, Johnson & Johnson, Pfizer, Qurebio, RDIF, Regeneron, Roche, Sciwind, Very, Wuhan Institute of Biological Products.
  • March 2, 2021

    Appointments and advancements for March 2, 2021

    New hires and promotions in the biopharma industry in Asia-Pacific, including: Immunoscape, Innocare, Sumitomo Dainippon, Xwpharma.
  • March 2, 2021

    In the clinic for Feb. 23-March 1, 2021

    Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aivita Biomedical, Altimmune, Ampio, Aslan, Biontech, Chimerix, Constant, Glaxosmithkline, Gtreebnt, I-Mab, Innovation, Innovent Biologics, LG Chem Life Sciences, Neurorx, Novavax, Opthea, Partner, Pfizer, Redhill, Regeneron, Regentree, Revive, Samsung Bioepis, Stero, Takeda, Takis, Theravance, Union.
Read More

Authors

  • Mark McCarty
  • Mari Serebrov
  • Marie Powers
More Authors
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing